YOLFTbeta
SWS Hemodialysis Care Co. Ltd. A

SWS Hemodialysis Care Co. Ltd. A

688410 · SHG · Healthcare / Medical Devices

10.88CNY+0.11 (+1.02%)

Price History

Full chart

Market Stats

Previous Close10.77
Open10.77
Day Range10.70 – 11.27
52-Week Range8.86 – 12.66
Volume12.19M
Market Cap4.20B
P/E (TTM)20.84
Forward P/E0.00
EPS0.45
Dividend Yield4.26%
Beta0.47
50-Day Avg10.34
200-Day Avg11.11

About

SWS Hemodialysis Care Co., Ltd. research, develops, produces, and sells blood purification equipment and consumables in China and internationally. It offers blood purification equipment, dialysis disposables, and dialysis center intelligent management system, as well as operates chain dialysis centers. The company was founded in 2001 and is headquartered in Chongqing, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Guangyong Gao
  • Employees1.44K
  • HeadquartersNo.1 Ciji Road, Chongqing, China, 401123, China
  • Websitehttps://www.swskj.com

Leadership

  • Mr. Guangyong GaoGM & Chairman of the Board · b. 1969
  • Ms. Shangling YuDeputy GM, Secretary, CFO & Director · b. 1975
  • Mr. Yingxiang RenDeputy GM & Director · b. 1976
  • Mr. Jin TongDeputy GM & Director · b. 1982
  • Wei Wei ZhangAccounting Supervisor
  • Ms. Chun Yan DuanDeputy General Manager · b. 1977

Financials

Income Statement

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue254.41M283.28M382.01M690.11M567.27M806.91M
Growth (%)-+11.35%+34.85%+80.65%-17.80%+42.24%
Cost of Revenue147.89M168.56M215.47M345.55M310.38M401.59M
Gross Profit106.51M114.72M166.54M344.56M256.90M405.32M
Gross Margin41.87%40.50%43.60%49.93%45.29%50.23%
Operating Expense81.09M85.95M101.87M152.53M196.05M222.17M
Operating Income25.42M28.77M64.67M192.03M60.85M183.15M
Operating Margin9.99%10.16%16.93%27.83%10.73%22.70%
EBITDA--80.96M238.77M90.26M187.38M
EBITDA Margin--21.19%34.60%15.91%23.22%
Net Income20.62M19.47M59.24M194.50M70.89M145.89M
Net Income Margin8.10%6.87%15.51%28.18%12.50%18.08%
R&D17.12M17.74M23.13M37.67M54.24M62.78M
R&D as % of Total Revenue6.73%6.26%6.06%5.46%9.56%7.78%
Interest Expense2.93M1.61M799.95K162.25K283.61K275.13K
Interest Expense % of Total Revenue1.15%0.57%0.21%0.02%0.05%0.03%

Balance Sheet

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets607.58M555.92M1.93B1.94B2.01B2.35B
Total Liabilities238.53M166.49M410.27M240.26M333.26M567.74M
Total Equity364.97M386.68M1.52B1.70B1.69B1.78B
Cash144.56M171.55M1.44B772.48M631.44M572.88M

Cash Flow

Currency: CNY2020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-18.57M32.76M245.85M64.55M143.15M308.01M
Capital Expenditure22.94M28.08M12.95M112.52M83.18M156.14M
Free Cash Flow-41.51M4.69M232.90M-47.97M59.97M151.87M
Dividends Paid2.89M1.78M744.62K29.13M43.13M31.96M
FCF to OCF223.50%14.30%94.73%-74.31%41.90%49.31%
Dividend Paid to FCF-6.97%38.00%0.32%-60.72%71.92%21.05%

Earnings

Report DateFeb 27, 2023Apr 27, 2023
EPS Estimate--
EPS Actual0.170.52
Surprise--
TimingAfter-hoursPre-market

Key Statistics & Ratios

Market Cap4.20B
Enterprise Value3.04B
Trailing P/E20.84
Forward P/E0.00
Price / Sales4.59
Price / Book2.46
EPS0.45
Book Value9.60
Revenue (TTM)913.38M
Gross Profit (TTM)480.72M
EBITDA220.54M
Profit Margin20.28%
Operating Margin15.67%
Return on Equity10.48%
Return on Assets5.61%
Shares Outstanding447.44M
Shares Float191.28M
Beta0.47
Dividend Yield4.26%
Dividend Rate0.40
Payout Ratio0.00%

Dividends

20261×
0.20Jul 10, 2026
20251×
0.07Jun 17, 2025
20241×
0.14Jul 9, 2024
20231×
0.10Oct 12, 2023

Stock Splits

  • Jul 10, 20261.4:1
  • Jul 9, 20241.49:1
  • Oct 12, 20231.49:1